presse/presse.htm




 
 
 
05/27/2011
   
   
APTAR PHARMA’S NASAL SPRAY DEVICE CHOSEN FOR PAIN MANAGEMENT
 
   
SPRIX® (Kétorolac Trométhamine), Nasal Spray, which uses an Aptar Pharma nasal spray pump, is the first non-opioid nasal spray to hit the U.S. market in the field of pain management. World leader in the development and manufacturing of nasal...
 
05/09/2011
   
   
RECORD ATTENDANCE AT RDD EUROPE 2011 CONFERENCE AFFIRMS CONTINUED STRONG INTEREST IN PULMONARY AND NASAL DRUG DELIVERY
 
   
RDD® Europe 2011 in Berlin brought together pulmonary and nasal drug delivery experts from more than 30 countries for a unique exchange of knowledge, expertise, science and business networking. 465 delegates involved in pulmonary and nasal d...
 
04/07/2011
   
   
APTAR PHARMA REGISTERS ITS CONTRACT TEST LABORATORIES
 
   

Aptar Pharma's French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as Contract Test Laboratories for extractables testing with the U.S. Food and Drug Administration (FDA).

 
11/25/2010
   
   
REGISTER NOW TO ATTEND THE RDD EUROPE 2011 SCIENTIFIC CONFERENCE TO BE HELD MAY 3-6, IN BERLIN, GERMANY
 
   
The Respiratory Drug Delivery (RDD®) Europe 2011 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Berlin, Germany, May 3-6, 2011. The joint organizers of this prestigious event, RDD Onlin...
 
10/07/2010
   
   
A PANEL OF DOCTORS AND PATIENTS CONFIRM A MAJOR ADVANCE IN NASAL SPRAYS
   
Aptar Pharma unveiled the brand name of its latest innovation,Latitude®, at the CPhI/ICSE international exhibition which was held in Paris from October 5th to 7th 2010. This novel side-actuated nasal spray is protected by several patents. The...
 
04/06/2010
   
   
PFEIFFER AND VALOIS ANNOUNCE THE REALIGNMENT OF THEIR PHARMACEUTICAL BUSINESSES UNDER A COMMON BRAND - APTAR PHARMA, AND UNVEIL THEIR NEW VISUAL IDENTITIES
   

This market-focused realignment will make it even easier for customers to do business with Aptargroup through a wider and innovative range of products and services available under the new Aptar Pharma brand.

 
10/30/2009
   
   
VALOIS PHARMA, THE WORLD’S LEADING MANUFACTURER OF HYDROFLUOROALKANE (HFA) METERING VALVES FOR PRESSURIZED METERED DOSE INHALERS (PMDIS), HAS CO-ORGANIZED THE FIRST CHINESE PMDI HFA TRAINING SESSION.
 
   
Valois Pharma, world leader in nasal and pulmonary drug delivery devices, has co-organized with the SFDA (Chinese State Food and Drug Administration) training centre, through Aptar Pharma Asia, the first Chinese training session on HFA pMDI d...
 
09/22/2009
   
   
WITH THE EUROPEAN LAUNCH OF INSTANYL® - NYCOMED’S INTRANASAL FENTANYL SPRAY WHICH USES A VALOIS PHARMA VP7 PUMP - NASAL SPRAY IS CONFIRMED AS AN EFFECTIVE ROUTE FOR SYSTEMIC DELIVERY OF ACTIVE INGREDIENTS
   
World leader in nasal and pulmonary drug delivery devices, Valois Pharma worked closely with Nycomed to develop the spray device which allows fentanyl to be delivered intranasally for the first time to cancer patients suffering from breakthro...
 
09/21/2009
   
   
PFEIFFER AND VALOIS PHARMA ANNOUNCE RESOUNDING SUCCESS FOR THE 4TH INDIAN NASAL AND PULMONARY DRUG DELIVERY SYMPOSIUM FOCUSED ON “REGULATORY CHALLENGES: A PERSPECTIVE”
 
   
In association with the Indian Pharmaceutical Association, Pfeiffer and Valois Pharma, world leaders in nasal and pulmonary drug delivery devices, co-organized, through Aptar Pharma India, the Fourth International Symposium on Nasal and Pulmo...
 
05/25/2009
   
   
RESPIRATORY PRODUCT OPINION LEADERS MEET IN LISBON
   

RDD® Europe 2009 brought together pulmonary and nasal drug delivery experts from 30 countries for a unique exchange of knowledge and expertise.

 
05/05/2009
   
   
VALOIS PHARMA’S PROHALER® DRY POWDER INHALER SECURES DOSE DELIVERY FOR ASTHMA SUFFERERS
   

For World Asthma Day, Valois Pharma is unveiling the results of a clinical study with patients suffering from asthma and chronic obstructive pulmonary disease (COPD) using its proprietary Dry Powder Inhaler Prohaler®.

 
03/17/2009
   
   
A PREVIEW OF VALOIS PHARMA’S SIDE-ACTUATED NASAL SPRAY DEVICE
   
Valois Pharma will unveil a new and innovative side-actuated device for nasal drug delivery at the upcoming Nasal Drug Delivery conference, organized by Management Forum and to be held in London on April 1st and 2nd. This easy to use device, ...
 
 
site map site search print page french version